TCI N1019, with the CAS number 944451-08-5, is a ruthenium-based complex used as an asymmetric catalyst in organic synthesis. This compound is specifically designed to facilitate the formation of chiral products by promoting enantioselective reactions. In laboratory settings, it plays a crucial role in the development of complex organic molecules with high stereochemical control. Its unique structure includes a ruthenium ion coordinated with a binap ligand, which is known for its high asymmetric activity. This makes it a valuable tool for chemists aiming to produce compounds with specific stereochemistry.
The compound's effectiveness stems from its ability to accelerate chemical reactions without significant degradation, enhancing both efficiency and cost-effectiveness. Its stability under certain conditions ensures long-term usability and ease of storage. Additionally, the compound’s chiral nature allows for the selective formation of stereoisomers, which is essential in the synthesis of biologically active compounds. These properties make it a preferred choice for researchers working in asymmetric catalysis.
In Indonesian laboratories, TCI N1019 is commonly used in organic chemistry research, particularly in the development of pharmaceutical compounds and bioactive molecules. Its application is widespread in academic and industrial settings where precise control over stereochemistry is required. Researchers rely on this compound to achieve high yields of chiral products, which are critical in drug development and other advanced chemical processes.
TCI brochures (PDF)
- Ruthenium Complex Catalysts for Asymmetric Hydrogenation to Optically Active Amines 2025-11-10 · p. 2
- Hydrogenation Catalysts 2025-11-10 · p. 7
Related TCI products
- Asymmetric Catalysis: This compound is ideal for enantioselective reactions, enabling the synthesis of chiral molecules with high stereocontrol.
- Pharmaceutical Development: Its ability to produce specific stereoisomers makes it essential in the creation of bioactive compounds and drug candidates.
- Organic Synthesis Research: It supports the development of complex organic structures, particularly in academic and industrial research environments.
- Chiral Ligand Studies: The compound's binap ligand is widely used in studies focused on asymmetric catalysis and ligand design.
- Bioactive Compound Synthesis: Its role in creating stereospecific products is crucial in the development of pharmaceutical and agrochemical compounds.
| Brand | TCI |
|---|---|
| CAS number | 944451-08-5 |
| Molecular formula | — |
| Purity | — |
| Category | Chemistry > Asymmetric Synthesis > Chiral Catalysts, Chiral Ligands, Chiral Reagents |
| Pack sizes | — |
| Physical form | — |
| Storage | Store in a cool, dry place away from light and moisture |
This compound should be stored in a cool, dry environment, away from direct light and moisture to maintain its stability and effectiveness. It is recommended to use airtight containers to prevent exposure to air and humidity, which could affect its performance. In laboratory settings, it should be handled with appropriate personal protective equipment, such as gloves and safety goggles, to ensure safe usage. Proper ventilation is also essential when working with this material to minimize any potential risks. Due to its chemical nature, it should be stored separately from incompatible substances to avoid any adverse reactions. Regular monitoring of storage conditions is advised to ensure the compound remains in optimal condition for use.
—
Product Categories
- Asymmetric SynthesisChiral Catalysts, Chiral Ligands, Chiral ReagentsHydrogenation [Asymmetric Synthesis]
- Catalysis and Inorganic ChemistryHydrogenation [Catalysis]Asymmetric Hydrogenation Catalysts
- Catalysis and Inorganic ChemistryTransition Elements [Catalysis and Inorganic Chemistry]Ruthenium [Catalysis and Inorganic Chemistry]
![944451-08-5 [NH2Me2][(RuCl((R)-xylbinap))2(mu-Cl)3] - AMI Scientific](http://amiscientific.com/cdn/shop/files/TCI2510N1019.jpg?v=1767130681&width=1445)